Fosfomycin calcium tablets
Function and Efficacy
This product is a broad-spectrum antibiotic. It inhibits the early synthesis of bacterial cell walls, which leads to the death of bacteria. This product has a wide antibacterial spectrum and has a certain antibacterial effect on most Gram-positive and Gram-negative bacteria. The antibacterial spectrum of this product includes Staphylococcus aureus, Escherichia coli, Shigella, Serratia, Shigella, Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacter aerogenes.
Indication
Oral administration is suitable for the following infections caused by pathogens sensitive to fosfomycin: 1. Intestinal infections: bacterial enteritis, bacillary dysentery. 2. Urinary tract infections: cystitis, pyelonephritis, urethritis. 3. Dermatological and soft tissue infections: furunculosis, anthrax, sweat gland inflammation, lymphadenitis, folliculitis. 4. Respiratory tract infections: nasopharyngitis, tonsillitis, tracheitis, early chronic bronchitis. 5. Ophthalmology: sty, dacryocystitis. 6. Gynecology: vaginitis, cervicitis.
Usage and Dosage
For oral administration, adults take 2-4 g of fosfomycin acid per day; children take 50-100 mg/kg per day based on body weight, divided into 3-4 doses.
Adverse Reactions
Mainly mild gastrointestinal reactions, such as nausea, decreased appetite, upper abdominal discomfort, loose stools or mild diarrhea, etc. Generally, it does not affect the continued use of the drug. Occasionally, skin rash, eosinophilia, and elevated alanine aminotransferase may occur. No toxic reactions to the kidneys or blood system were observed.
Precautions
Not yet clear.
Drug Interactions
1. It has a synergistic effect when used in combination with beta-lactams against Staphylococcus aureus (including methicillin-resistant Staphylococcus aureus) and Pseudomonas aeruginosa. 2. It has a synergistic effect when used in combination with aminoglycosides. 3. There is no cross-resistance with other antibiotics.
Storage
Sealed and stored in a dry place. Valid for two years
Packaging Specification
Calculated as C3H7O4P 0.2g (200,000 units)
Manufacturer
Liaoning PHARMA-UNION Pharmaceutical Co., Ltd.
-
Founded in:
2008-05-12 -
Address:
122A Xianghuai Road, Benxi Economic Development Zone -
Tax NO.:
91210500673786474R -
Registered Funds:
110 million yuan -
Email: